Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

TransCode Therapeutics ( (RNAZ) ) has shared an announcement.

TransCode Therapeutics shares are trading lower by 16% during Monday's session. The company announced a 1-for-33 reverse ...

TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company committed to more effectively treating cancer using RNA ...

BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced ...

TransCode Therapeutics (RNAZ) has entered into a securities purchase agreement with certain institutional investors. The aggregate gross cash proceeds are expected to be approximately $8M before ...

TransCode Therapeutics, Inc. BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), the RNA Oncology Company™ committed to more effectively treating cancer using ...

https://www.tipranks.com/news/company-announcements/enanta-pharmaceuticals-reduced-reporting-potential-impact-on-investor-appeal-and-stock-volatility TransCode ...

Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Oil & Gas, Financials and Industrials sectors propelled shares higher. At the close in NYSE,... Investing.com – U.S.

TransCode Therapeutics, Inc. (NASDAQ:RNAZ), a biopharmaceutical company specializing in ... with 9,480,060 shares present or represented by proxy at the meeting. In other recent news, TransCode ...